Aspirin Therapy for Colorectal Cancer With PIK3CA Mutation: Simply Complex!

被引:14
|
作者
Fuchs, Charles S. [1 ]
Ogino, Shuji [1 ]
机构
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
关键词
NF-KAPPA-B; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; RANDOMIZED-TRIAL; BETA-CATENIN; COLON-CANCER; ADENOMAS; PATHWAY; PREVENTION; ACTIVATION; EXPRESSION;
D O I
10.1200/JCO.2013.52.0080
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:4358 / 4361
页数:4
相关论文
共 50 条
  • [41] PIK3CA Mutation Associates with Improved Outcome in Breast Cancer
    Kalinsky, Kevin
    Jacks, Lindsay M.
    Heguy, Adriana
    Patil, Sujata
    Drobnjak, Marija
    Bhanot, Umeshkumar K.
    Hedvat, Cyrus V.
    Traina, Tiffany A.
    Solit, David
    Gerald, William
    Moynahan, Mary Ellen
    CLINICAL CANCER RESEARCH, 2009, 15 (16) : 5049 - 5059
  • [42] Aspirin-Induced Chemoprevention and Response Kinetics Are Enhanced by PIK3CA Mutations in Colorectal Cancer Cells
    Zumwalt, Timothy J.
    Wodarz, Dominik
    Komarova, Natalia L.
    Toden, Shusuke
    Turner, Jacob
    Cardenas, Jacob
    Burn, John
    Chan, Andrew T.
    Boland, C. Richard
    Goel, Ajay
    CANCER PREVENTION RESEARCH, 2017, 10 (03) : 208 - 218
  • [43] The PIK3CA Gene as a Mutated Target for Cancer Therapy
    Gustin, John P.
    Cosgrove, David P.
    Park, Ben Ho
    CURRENT CANCER DRUG TARGETS, 2008, 8 (08) : 733 - 740
  • [44] Investigating the chemotherapeutic effects of aspirin in mutant PIK3CA breast cancer
    Henry, Whitney
    Toker, Alex
    CANCER RESEARCH, 2015, 75
  • [45] PIK3CA Mutation Predicts Poor Prognosis in Stage I-III Colorectal Cancer
    Ogino, S.
    Nosho, K.
    Kirkner, G. J.
    Shima, K.
    Irahara, N.
    Kure, S.
    Chan, A. T.
    Engelman, J. A.
    Kraft, P.
    Cantley, L. C.
    Giovannucci, E. L.
    Fuchs, C. S.
    MODERN PATHOLOGY, 2009, 22 : 143A - 143A
  • [46] PIK3CA mutation status in Japanese lung cancer patients
    Kawano, Osamu
    Sasaki, Hidefumi
    Endo, Katsuhiko
    Suzuki, Eriko
    Haneda, Hiroshi
    Yukiue, Haruhiro
    Kobayashi, Yoshihiro
    Yano, Motoki
    Fujii, Yoshitaka
    LUNG CANCER, 2006, 54 (02) : 209 - 215
  • [47] Mutation and functional analysis of PIK3CA and PIK3R1 in endometrial cancer
    Cheung, Lydia Wai Ting
    Hennessy, Bryan T.
    Li, Jie
    Yu, Shuangxing
    Myers, Andrea P.
    Djordjevic, Bojana
    Lu, Yiling
    Stemke-Hale, Katherine
    Zhang, Fan
    Ju, Zhenlin
    Cantley, Lewis C.
    Scherer, Steve E.
    Liang, Han
    Lu, Karen H.
    Russell, Broaddus R.
    Mills, Gordon B.
    CANCER RESEARCH, 2011, 71
  • [48] PIK3CA mutation in gastric cancer and the role of microsatellite instability status in mutations of exons 9 and 20 of the PIK3CA gene
    Polom, Karol
    Marrelli, Daniele
    Roviello, Giandomenico
    Pascale, Valeria
    Voglino, Costantino
    Vindigni, Carla
    Generali, Daniele
    Roviello, Franco
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 27 (07): : 963 - 969
  • [49] PIK3CA Gene Mutation Analysis in Breast Cancer Using the therascreen PIK3CA RGQ Assay in FFPE Specimen Type
    Cai, L.
    Overman, W.
    Hood, S.
    Zimmer, A.
    Wang, D.
    Kam-Morgan, L.
    Chenn, A.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2020, 22 (11): : S65 - S65
  • [50] PIK3CA Activating Mutation in Colorectal Carcinoma: A Stratified Analysis in a Prospective Cohort
    Rosty, C.
    Young, J. P.
    Walsh, M. D.
    Clendenning, M.
    Jenkins, M. A.
    Win, A. K.
    Southey, M. C.
    Parry, S.
    Hopper, J. L.
    Giles, G. G.
    Williamson, E.
    English, D. R.
    Buchanan, D. D.
    MODERN PATHOLOGY, 2013, 26 : 175A - 176A